Pacer BioThreat Strategy ETF (VIRS) |
| 40.025 0.01 (0.03%) 10-10 13:16 |
| Open: | 40.03 |
| High: | 40.03 |
| Low: | 40.0032 |
| Volume: | 1,985 |
| Market Cap: | 4(M) |
| PE Ratio: | 28.73 |
| Exchange: | Chicago Board Options Exchange |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 31.17 |
| Resistance 1: | 29.74 |
| Pivot price: | 28.76 |
| Support 1: | 27.43 |
| Support 2: | 22.83 |
| 52w High: | 40.03 |
| 52w Low: | 30.3021 |
The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. It is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 15 Aug 2024
WMT Surge: 10 ETFs with largest Walmart holdings as retailer’s stock jumps to record high - Seeking Alpha
Mon, 17 Jun 2024
How Is Pharma Innovating as Patent Cliffs Loom? - CMC Markets
Fri, 21 Jan 2022
ETFs Most Exposed To Netflix’s Epic Sell-Off - Yahoo Finance
Mon, 29 Jun 2020
UBS Expands SMAs to Third-Party Asset Managers: Portfolio Products - ThinkAdvisor
Tue, 14 Apr 2026
Tue, 14 Apr 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
